Literature DB >> 2510982

Anorexia, weight loss, and diarrhea as presenting symptoms of angiokeratoma corporis diffusum (Fabry-Anderson's disease).

G F Nelis1, G J Jacobs.   

Abstract

Fabry-Anderson's disease or angiokeratoma corporis diffusum (ACD) is an X-linked sphingolipidosis with a systemic character and occurs in 2-5 per million births (1-3). The basic defect is the absence of a lysosomal enzyme x-galactosidase A. This enzyme is necessary for the metabolization of ceramide trihexoside (globotriglycosyl ceramide), a breakdown product of cell membranes (4, 5). Clinically the disease is characterized by cutaneous angiokeratoma's and severe pain in the limbs from the second decade, followed by progressive renal insufficiency and cardiovascular and cerebrovascular damage in the third or fourth decade (6-8). In patients with established ACD, gastrointestinal symptoms have been described incidentally, mainly mild diarrhea (9, 10). We describe a kindred with ACD showing two extraordinary clinical features: (1) Anorexia, weight loss, and diarrhea were the presenting symptoms and antedated limb pain by many years, which has not been described before. (2) The disease was associated with another rare X-linked disorder: hypoplastic amelogenesis imperfecta.

Entities:  

Mesh:

Year:  1989        PMID: 2510982     DOI: 10.1007/bf01540061

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  THE NEUROPATHOLOGY OF HEREDITARY DYSTOPIC LIPIDOSIS.

Authors:  A N RAHMAN; R LINDENBERG
Journal:  Arch Neurol       Date:  1963-10

2.  Angiokeratoma corporis diffusum. A clinical study of eight affected families.

Authors:  D WISE; H J WALLACE; E H JELLINEK
Journal:  Q J Med       Date:  1962-04

3.  [Enterocolitis as a symptom of angiokeratoma corporis diffusum (Ruiter-Pompen-Wyers-Kühnau thesaurismosis)].

Authors:  R G VAN WAYJEN
Journal:  Ned Tijdschr Geneeskd       Date:  1958-09-27

4.  Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports.

Authors:  A W M POMPEN; M RUITER; H J G WYERS
Journal:  Acta Med Scand       Date:  1947-06-30

Review 5.  Inherited defects in tooth structure.

Authors:  S Rao; C J Witkop
Journal:  Birth Defects Orig Artic Ser       Date:  1971-06

6.  Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.

Authors:  R O Brady; J F Tallman; W G Johnson; A E Gal; W R Leahy; J M Quirk; A S Dekaban
Journal:  N Engl J Med       Date:  1973-07-05       Impact factor: 91.245

7.  Intestinal manifestations of Fabry's disease.

Authors:  J W Rowe; J I Gilliam; T A Warthin
Journal:  Ann Intern Med       Date:  1974-11       Impact factor: 25.391

8.  Fabry's disease--glycolipid lipidosis. Histochemical and electron microscopic studies of two cases.

Authors:  P Frost; Y Tamala; G L Spaeth
Journal:  Am J Med       Date:  1966-04       Impact factor: 4.965

9.  B.C.P. Jansen Institute, University of Amsterdam, Amsterdam, The Netherlands.

Authors:  F A Van den Bergh; P J Rietra; A J Kolk-Vegter; E Bosch; J M Tager
Journal:  Acta Med Scand       Date:  1976

10.  Fabry's disease: alpha-galactosidase deficiency.

Authors:  J A Kint
Journal:  Science       Date:  1970-02-27       Impact factor: 47.728

View more
  2 in total

1.  Colonic involvement in Fabry's disease.

Authors:  C I Jack; A I Morris; D G Nasmyth; N Carroll
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

2.  Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.

Authors:  E R Smith; I Ruderman; S Bruell; K M Nicholls; T D Hewitson; A S Talbot; S G Holt
Journal:  Osteoporos Int       Date:  2022-05-16       Impact factor: 5.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.